Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.95B 583M 512M 478M 439M 821M 55.84B 842M 5.67B 2.22B 27.63B 2.19B 2.14B 95.52B P/E 2026 *
8.68x
P/E 2027 * 7.7x
Enterprise Value 3.95B 583M 512M 478M 439M 821M 55.84B 842M 5.67B 2.22B 27.63B 2.19B 2.14B 95.52B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.52x
Free-Float
45.7%
Yield 2026 *
5.19%
Yield 2027 * 5.84%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-10.02%
3 months-10.02%
6 months-29.30%
Current year-29.30%
Current year 0.49
Extreme 0.4949
0.55
1 year 0.49
Extreme 0.4949
0.7
3 years 0.49
Extreme 0.4949
0.86
5 years 0.49
Extreme 0.4949
0.86
10 years 0.49
Extreme 0.4949
1.76
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-03
Comptroller/Controller/Auditor 48 2025-06-03
Corporate Secretary 37 2026-07-08
Director TitleAgeSince
Director/Board Member 67 2011-02-09
Director/Board Member 69 2018-06-11
Director/Board Member 82 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
-10.02%-.--% - - 577M
+0.89%+0.27%-7.04%-4.42% 13.56B
+1.53%-0.42%-29.00%-50.05% 5.16B
+3.46%+4.59%+6.75%+6.09% 4.9B
+0.72%-3.02%-0.48%-32.50% 4.1B
+4.58%+1.09%+4.38%-4.39% 3.63B
+1.78%-2.00%-1.39%-2.89% 3.6B
+1.40%-0.31%-3.45%+11.15% 3.47B
+0.06%-2.31%-15.38%-24.02% 2.43B
+2.94%+3.17%+0.39%+47.42% 1.87B
Average +0.73%+0.73%-5.02%-5.96% 4.75B
Weighted average by Cap. +1.56%+0.72%-5.89%-8.87%

Financials

2026 *2027 *
Net sales 6.98B 1.03B 906M 846M 776M 1.45B 98.77B 1.49B 10.03B 3.92B 48.87B 3.87B 3.79B 169B 7.56B 1.12B 981M 916M 841M 1.57B 107B 1.61B 10.86B 4.25B 52.94B 4.19B 4.1B 183B
Net income 454M 67.12M 58.98M 55.06M 50.53M 94.58M 6.43B 96.91M 653M 255M 3.18B 252M 247M 11B 514M 75.84M 66.64M 62.2M 57.09M 107M 7.26B 109M 738M 288M 3.59B 285M 279M 12.43B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.082CNY
Average target price
4.601CNY
Spread / Average Target
+49.29%

Annual profits - Rate of surprise